Phreesia, Inc., (PHR) is a leading healthcare technology company based in the United States. PHR is renowned for its cutting-edge patient intake platform, which is devoted to revolutionizing the healthcare experience for both patients and care providers. The company is publically traded on the New York Stock Exchange under the ticker symbol ‘PHR’.
Founded in 2005, Phreesia has effectively transformed the traditional pen-and-paper process of patient registration into a digitized, seamless process. Their mission is to improve and modernize healthcare through the use of sophisticated technology, and thereby contribute to a better patient experience. The unique Phreesia platform specializes in facilitating patient registration, insurance verification, payments and reporting, mobile registration, and clinical support, among other crucial functions. These services result in enhanced operational efficiency, a reduction in administrative tasks, the opportunity for healthcare providers to focus more attention on patient care, and a boost in overall patient satisfaction.
In the years since its establishment, Phreesia has developed a reputation for innovation and the consistent delivery of high-quality solutions. Consequently, it has garnered a significant customer base, serving more than 50,000 providers across the country. As a testament to the effectiveness of their advanced platform, Phreesia manages over 60 million patient visits annually. The experience that the company has amassed, plus its continuous investment in research and development, ensures a strong, dynamic presence within the booming health-tech industry.
Phreesia, driven by a highly skilled management team, works diligently to provide integrated, user-friendly solutions to the healthcare sector. They trust that their advanced technological solutions improve the overall healthcare delivery system by making it more efficient and patient-centric, which eventually promotes better clinical outcomes. Despite the intricate complexities facing the healthcare sector, the Phreesia team uses technology as a tool to make healthcare as accessible and effective as possible.
One of Phreesia's significant achievements is the company’s commitment to diversity and inclusion, both in its own workplace and within the larger healthcare community. They strive to create an environment that nurtures innovation, and appreciate the value of different perspectives and ideas in achieving this.
To sum up, Phreesia, Inc. is an innovative force in the health-tech industry, successfully bridging the gap between healthcare providers and their patients through their unique technology platform. The company's commitment to enhancing patient experience, improving operational efficiency and fostering a diverse and inclusive workspace continues to propel its growth in the rapidly evolving healthcare landscape.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Amy Beth VanDuyn, Senior Vice President of Human Resources at Phreesia, Inc. (NYSE:PHR), filed a Form 4 detailing the disposition of 2,876 shares of Common Stock. This transaction, dated September 18, 2026, was not a sale but represented shares withheld by Phreesia to cover tax withholding obligations related to the settlement of restricted stock units (RSUs). After this event, VanDuyn directly holds 260,521 shares of Common Stock.
Phreesia (PHR) reported improved Q2 fiscal 2027 results with 10% revenue growth and a significant increase in adjusted EBITDA, leading to debt retirement. Despite these positive financial indicators, Wall Street analysts are divided due to concerns over slowing growth, increased AI spending, and reduced visibility in future revenue forecasting. While some firms raised price targets acknowledging margin improvements and cash flow, others downgraded the stock citing elevated risks.
_07_03_2026_03_50_21_133108.jpg)
Evan Roberts, President of Provider Solutions at Phreesia, Inc. (NYSE:PHR), acquired 8,113 restricted stock units (RSUs) on September 14, 2026. These RSUs represent 50% of his cash bonus for the first half of the fiscal year, converted at a 115% premium. Following this transaction, Roberts directly owns 1,042,614 shares of Phreesia common stock.
The Schall Law Firm is reminding investors of a class action lawsuit against Phreesia, Inc. (NYSE: PHR) for alleged securities fraud. Investors who purchased shares between May 8, 2025, and March 30, 2026, are encouraged to contact the firm by July 13, 2026, to potentially lead the lawsuit. The lawsuit claims Phreesia made false and misleading statements about its growth outlook and pharmaceutical marketing commitments.
Tocqueville Asset Management L.P. has acquired a new stake in Phreesia, Inc. (NYSE:PHR), purchasing 325,000 shares valued at approximately $3.34 million. This acquisition gives Tocqueville a 0.53% stake in the company, with institutional investors collectively owning 92.10% of Phreesia. Analysts have a mixed sentiment on the stock, with a consensus "Hold" rating and an average price target of $16.65, while Phreesia recently exceeded quarterly revenue and earnings expectations.